News
10 Health Care Stocks Whale Activity In Today's Session
19 Jun 24
Options
BMO Capital Maintains Outperform on Sarepta Therapeutics, Maintains $170 Price Target
18 Jun 24
News, Price Target, Analyst Ratings
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 9 Analysts
14 Jun 24
Analyst Ratings
BMO Capital Maintains Outperform on Sarepta Therapeutics, Maintains $170 Price Target
14 Jun 24
News, Price Target, Analyst Ratings
Pfizer Phase III DMD Gene Therapy Study Misses Goal
13 Jun 24
News, Health Care, FDA, Markets, Analyst Ratings, Trading Ideas, General
10 Health Care Stocks Whale Activity In Today's Session
31 May 24
Options
Piper Sandler Initiates Coverage On Sarepta Therapeutics with Overweight Rating, Announces Price Target of $157
31 May 24
News, Price Target, Initiation, Analyst Ratings
Why Sarepta Therapeutics Stock Is Rising Today
30 May 24
News, Movers
Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
29 May 24
News
Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months
28 May 24
Biotech, News, Downgrades, Health Care, Price Target, Top Stories, Analyst Ratings, Movers, Trading Ideas, General
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
28 May 24
News, Intraday Update, Markets, Movers, Trading Ideas
RBC Capital Downgrades Sarepta Therapeutics to Sector Perform, Lowers Price Target to $142
28 May 24
News, Downgrades, Price Target, Analyst Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
24 May 24
Options
Jim Cramer: This Industrial Stock Is Doing 'Very Well'; Here's His Take On Palantir
22 May 24
Long Ideas, News, Top Stories, Markets, Media, Trading Ideas
12 Analysts Have This To Say About Sarepta Therapeutics
20 May 24
Analyst Ratings
Needham Reiterates Buy on Sarepta Therapeutics, Maintains $166 Price Target
20 May 24
News, Price Target, Reiteration, Analyst Ratings
Mizuho Maintains Buy on Sarepta Therapeutics, Raises Price Target to $179
17 May 24
News, Price Target, Analyst Ratings
Oppenheimer Upgrades Sarepta Therapeutics to Outperform, Announces $180 Price Target
14 May 24
News, Upgrades, Price Target, Analyst Ratings
Sarepta Therapeutics Shares Move Higher; Traders Circulate STAT News Report 'Young boy dies in trial for Pfizer Duchenne gene therapy.' BZ NOTE: Co Makes Competing DMD Drug
7 May 24
News, Trading Ideas
JP Morgan Maintains Overweight on Sarepta Therapeutics, Lowers Price Target to $175
3 May 24
News, Price Target, Analyst Ratings
Press releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 May 24
Press Releases
Sarepta Therapeutics Set to Join S&P MidCap 400
29 May 24
Press Releases
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
3 May 24
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Apr 24
Press Releases
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
24 Apr 24
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Mar 24
Press Releases